E-pharma startups seek more clarity on data privacy

New Delhi: E-pharmacy players on Tuesday said they support the government’s draft e-Pharmacy policy but look forward to more clarity on the data privacy and data management.

Digital health platforms said they are in total support of the draft rules, as it would bring affordability and transparency for consumers, and would oppose the nation-wide strike called by the All India Organisation of Chemists and Druggists (AIOCD) on September 28, 2018.

“Few areas we would like additional clarity on

would be data privacy and data management,” said Prashant Tandon, co-founder, 1mg, on being asked about problems faced by the sector.

The online pharma players were speaking at a media briefing here.

Tandon further said: “There is a parallel Sri Krishna Committee for digital data, which is going on… We would prefer a clarity whether we have to comply with it.

Talking of the recent opposition to the government’s draft policy, the stakeholders said e-pharmacies would empower consumers and provide them multiple options to help them make an informed choice while buying their medicines.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert